The story of Viagra presents a complex picture for shareholders. While the initial launch generated substantial profits, the lapse of its patent opened the door to off-brand competitors, dramatically diminishing sales. https://sociallawy.com/story12236640/sildenafil-and-pharma-a-volatile-opportunity